CCI
BPMC

Columbus Circle Investors’s Blueprint Medicines BPMC Stock Holding History

Columbus Circle Investors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$6.05M Buy
+53,978
New +$5.69M 0.27% 107
2018
Q2 		– Sell
-50,097
Closed -$4.59M – 192
2018
Q1 		$4.59M Sell
50,097
-193
-0.4% -$16.6K 0.09% 165
2017
Q4 		$3.79M Buy
+50,290
New +$3.54M 0.07% 159

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Columbus Circle Investors's BPMC Position: Q4 2020 in Review

Columbus Circle Investors opened a new position in Blueprint Medicines (BPMC) in Q4 2020: 53,978 shares worth $6.05M. The stake represents 0.27% of the portfolio and ranks #107 among its holdings. This is a return to the name: Columbus Circle Investors previously reported a position in BPMC as recently as Q1 2018.

Columbus Circle Investors first reported a position in BPMC in Q4 2017 and has held it in 3 quarters since. 279 funds tracked by Wall St. Rank hold BPMC as of Q4 2020.

  • Columbus Circle Investors held 53,978 shares of Blueprint Medicines worth $6.05M as of Q4 2020.
  • Blueprint Medicines was a new Columbus Circle Investors position in Q4 2020.
  • Blueprint Medicines made up 0.27% of Columbus Circle Investors's portfolio in Q4 2020, its #107 holding.
  • Columbus Circle Investors first reported a position in Blueprint Medicines in Q4 2017 and has held it in 3 quarters since.
  • 279 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.